Alzheimer Disease

Disease State Hub

Featured

Nutritional Pearl

an elderly person's hands holding a cane

Nutritional Pearl

How to Reduce the Risk of Dementia, Alzheimer Disease

12/02/2023

Your patient is a 46-year-old woman with a family history of dementia and obesity. Based on her family history, she asks you if there is a way to reduce her risk of developing dementia, and a way to stay...

12/02/2023

expert Q&A

expert Q&A

Cholinesterase Inhibitors for Neuropsychiatric Symptoms in Alzheimer Disease, Parkinson Disease

11/27/2023

Emile d’Angremont, MSc

In this interview, Emile d’Angremont, MSc, discusses the results of a recent study examining the use of cholinesterase inhibitors for the management of psychotic symptoms among patients with...

11/27/2023

NUTRITION411: THE PODCAST, EP. 31

Nutrition Strategies for Improved Cognitive Function in Patients With Alzheimer Disease

11/16/2023

Lisa Jones, MA, RDN, LDN, FAND

In this podcast episode, Lisa Jones, interviews Amylee Amos, PhD, RDN, IFMCP, about the practical and actionable nutrition strategies that dietitians can recommend to individuals managing Alzheimer disease...

11/16/2023

Interactive Features

Nutritional Pearl

How to Reduce the Risk of Dementia, Alzheimer Disease

12/02/2023

Pop Quiz

Estimated Number of Older Americans With Alzheimer Dementia by 2025

11/11/2023

Increasing age is a risk factor for Alzheimer dementia (AD), and as the US population grows older and lives longer, new and existing cases of AD are projected to rise as well. How many older Americans are...

11/11/2023

pop quiz

pop quiz

Non-Memory Concerns in Alzheimer Disease Assessment

09/29/2023

Individuals with Alzheimer disease may present with memory loss or other cognition concerns. Are you familiar with the non-memory symptoms that should determine if a patient needs further cognitive...

09/29/2023

Poll

Statins and Cognition

09/15/2023

Statin use has been controversial. Do they cause or protect against cognitive impairment? Tell us your thoughts via this poll.

09/15/2023

Poll

doctor with medical records talking to patient

Poll

Anticipated Updates to Alzheimer Disease Clinical Criteria

08/25/2023

Updated Alzheimer disease diagnostic guidelines are expected to be released in the coming months. What aspects of this new clinical criteria are you most anticipating? Let us know with this latest poll. ...

08/25/2023

Clinical Insights

expert Q&A

Cholinesterase Inhibitors for Neuropsychiatric Symptoms in Alzheimer Disease, Parkinson Disease

11/27/2023

Emile d’Angremont, MSc

In this interview, Emile d’Angremont, MSc, discusses the results of a recent study examining the use of cholinesterase inhibitors for the management of psychotic symptoms among patients with...

11/27/2023

NUTRITION411: THE PODCAST, EP. 31

Nutrition Strategies for Improved Cognitive Function in Patients With Alzheimer Disease

11/16/2023

Lisa Jones, MA, RDN, LDN, FAND

11/16/2023

NUTRITION411: THE PODCAST, EP. 30

Controversies in the Impact of Diet on Alzheimer Disease Prevention, Management

11/10/2023

Lisa Jones, MA, RDN, LDN, FAND

In this podcast episode, Lisa Jones, interviews Amylee Amos, PhD, RDN, IFMCP, about the key arguments and controversies surrounding specific diets in relation to Alzheimer disease prevention and management,...

11/10/2023

NUTRITION411: THE PODCAST, EP. 29

Practical Dietary Recommendations for Patients at Risk, Diagnosed With Alzheimer Disease

10/30/2023

Lisa Jones, MA, RDN, LDN, FAND

In this podcast episode, Lisa Jones interviews Amylee Amos, PhD, RDN, IFMCP, about how dietitians can effectively translate the latest research on diet and Alzheimer disease into practical dietary...

10/30/2023

Nutrition411: The Podcast, Ep. 28

The Impact of Dietary Choices on Alzheimer Disease Prevention

10/23/2023

Lisa Jones, MA, RDN, LDN, FAND

In this podcast episode, Lisa Jones interviews Amylee Amos, PhD, RDN, IFMCP, about research that suggests a potential link between dietary choices and the development or prevention of Alzheimer disease and...

10/23/2023

For more on the etiology of Alzheimer disease content, visit our Clinical Update page

The most common type of dementia, Alzheimer disease is a progressive disease that generally begins with mild memory loss and involves parts of the brain that control thought, memory, and language.

For more Alzheimer Disease content, visit the Clinical Insights page

Brain changes may begin 10+ years before symptoms appear. These changes include buildup of proteins that form amyloid plaques and tau tangles. This causes healthy neurons to stop functioning, lose connections with other neurons, and die.

For more neurology content, visit the Resource Center

occupational therapist, neurologist, geriatrician, psychiatrist, primary care physicians, geropsychologist

For more dementia content, visit the Disease State Hub

Memory loss that disrupts daily life
Difficulty completing familiar tasks at home, at work, or at leisure
Worsening judgment
Misplacing items & failure to retrace steps
Changes in mood, personality, or behavior

For more imaging content, visit the Resource Center

There is no single test to determine AD, but testing options include: computed tomography scan, magnetic resonance imaging, positron emission tomography scan, cerebrospinal fluid analysis, neurological examination

For more neurological diseases content, visit the Disease State Hub

Examples of cognitive, functional, and behavioral tests include: Ascertain Dementia 8, Activities Questionnaire, Mini-Cog Mini-Mental State Examination, Montreal Cognitive Assessment, Neuropsychiatric Inventory Questionnaire

For more traumatic brain injury content, visit the Resource Center

Age
Family history
Genetics
Mild cognitive impairment
Modifiable risk factors, like obesity, high cholesterol, poorly controlled type 2 diabetes

For more polls and quizzes, visit the interactive features page

An estimated 6.7 million Americans aged 65 years or older are living with AD (73% are aged 75 years or older)

For more patient education content, visit the Resource Center

By 2025, the number of people aged 65 or older with AD is projected to reach 7.2 million — a 7% increase from 2023.

Research Summaries

research summary

research summary

Updated Guidance on Antiamyloid Monoclonal Antibody Treatment in Alzheimer Disease

09/21/2023

Leigh Precopio

A new expert consensus was released by the American Academy of Neurology reviewing the currently available evidence on the efficacy and safety of antiamyloid monoclonal antibodies for the treatment of...

09/21/2023

Research Summary

In Small Trial, FDA-Approved Insomnia Treatment Decreases Alzheimer Proteins in Healthy Adults

09/07/2023

Anthony Calabro, MA

Researchers found that patients taking suvorexant had reduced levels of amyloid beta and tau phosphorylation, proteins that play a major role in neurodegeneration in Alzheimer disease.

09/07/2023

Research Summary

Research Summary

Can the MIND Diet Slow Cognitive Decline in Older Individuals?

08/15/2023

Anthony Calabro, MA

Can a dietary intervention known for reducing cardiovascular risk factors prevent cognitive decline in healthy older individuals? A team of researchers explored this question in a recent study.

08/15/2023

fda alert

FDA Converts Alzheimer Disease Treatment to Traditional Approval

07/28/2023

Leigh Precopio

The FDA has examined the results of a recent confirmatory trial to verify the clinical benefit of an amyloid beta-directed antibody for the treatment of Alzheimer disease.

07/28/2023

FDA Alert

FDA Approves First Treatment of Agitation in Patients With Alzheimer Dementia

05/15/2023

Jessica Ganga

Following two 12-week studies, the FDA has approved the first ever medication for treating agitation in patients with dementia due to Alzheimer disease.

05/15/2023

November 2023

Current Issue

November 2023

Volume 63

Issue 11

Sources

CDC.gov
2023 Alzheimer's Facts and Figures